Henrik Karl Nielsen: The World Health Organisation: Implementing the Right to Health

2003 ◽  
Vol 21 (04) ◽  
pp. 484-485
Author(s):  
Ole Espersen
Author(s):  
Tengku Noor Azira Tengku Zainudin ◽  
Mohd Zamre Mohd Zahir ◽  
Ahmad Azam Mohd Shariff ◽  
Ramalinggam Rajamanickam ◽  
Ong Tze Chin ◽  
...  

The right to health is recognised as a fundamental human right in the World Health Organisation (WHO) Constitution. In Malaysia, the enjoyment of the highest attainable standard of physical and mental health is a fundamental human right without discrimination for every human being. Consequently, the principle of the “right to health,” regardless of the legal status of an individual, is the driving force in creating acceptable standards of health care for all citizens. Even for individual who suffers from Covid-19, he still has a fundamental right to health. The issue of the right to health is whether the patients have any rights of their health? If they do have the right to health, the next issue is whether the hospitals are legally bound to follow such right, i.e. the right to health of the patients. Therefore, this paper aims to analyse and discuss the issues regarding the rights to health of the patients. Without the legal mechanism in recognising the right to health, it pointed out that is no such right. The method employed in this paper is qualitative based. The paper finds that although Malaysia does not have any specific legal framework about the right to health, the application of international legal mechanism can be referred to a guideline. Thus, it is important to have a specific legal framework by applying international legal mechanism in order to address this issue.


2022 ◽  
pp. 124-147
Author(s):  
Maral Törenli Çakıroğlu

The COVID-19 virus, which first appeared in Wuhan, China in December 2019 and spread quickly to the whole world in a few months, was defined as a pandemic by the World Health Organization on 12 March 2020. This process has inevitably brought along problems in many areas, including health, education, social, economics, law, psychology, politics, and international relations. The pandemic era is a period when we appreciate more than ever how valuable our fundamental rights and freedoms are. Of these rights, the right to health and patient rights are significantly adversely impacted. This chapter will evaluate human rights, especially patient rights, mostly affected during this pandemic period in Turkey. This chapter further presents that other states are also continuing to experience effects of the pandemic. Both Turkey and other states must be prepared for the patients to properly benefit from the healthcare system in future outbreaks and pandemics. Otherwise, human and patient rights will continue to suffer.


2019 ◽  
Vol 45 (3) ◽  
pp. 208-213
Author(s):  
Md. Habibe Millat ◽  
Mr. Christian Lohr ◽  
Ms. Mariana Carvalho

In October 2018, on behalf of the Bangladesh Parliament, I proposed to the 139th Assembly of the Inter Parliamentary Union (IPU) to adopt a resolution on “Achieving universal health coverage by 2030: The role of parliaments in ensuring the right to health” (Annex-1). After the acceptance of my proposal, I worked as a co-rapporteur along with Mr. Christian Lohr, Member of the National Council, Switzerland and Ms. Mariana Carvalho, Member of the Chamber of Deputies, Brazil for a year to consult with and gather inputs from the parliaments and parliamentarians across the world. After several intensive discussions, debates and consultations in different parts of the world, we presented a draft proposal to the IPU member parliaments before presented it to the IPU assembly. Later, following the final debate and discussion, 141st IPU assembly 2019 in Belgrade, Serbia approved this resolution. I believe this global tool will enable parliaments and parliamentarians to contribute in ensuring the highest attainable standard of health and global health targets by 2030. I am grateful to the Hon’ble Prime Minister of Bangladesh Jononetry Sheikh Hasina MP and the Hon’ble Speaker of Bangladesh Parliament Dr. Shirin Sharmin Chaudhury MP for their encouragement. I am also thankful to IPU President Ms Gabriela Cuevas Barron, IPU Secretary General Mr Martin Chungong and World Health Organization Director General Dr Tedros Adhanom Ghebreyesus for their regular guidance towards this initiative. My sincere appreciation goes to the colleagues from the Bangladesh Parliament, Ministry of Health and Family Welfare of Bangladesh, Ministry of Foreign Affairs of Bangladesh, IPU Secretariat and WHO Secretariat for their contribution in the process. I hope our parliaments and parliamentarians will take full advantage of this resolution in their work to make the right decisions when it’s come to those health issues. I am now looking forward to working together with my fellow parliamentarians from home and abroad to deliver the commitment we have made through the IPU resolution on universal health coverage. I would appreciate your comment, suggestion and advice in this regard.


2022 ◽  
pp. 311-332
Author(s):  
Rodolfo Andrade de Carvalho ◽  
Jorge Lima de Magalhães

Health gained a global prominence and became a right declared by the World Health Organization in 1948. In the 21st century, it is understood as a complete well-being of the individual, far beyond the absence of disease. In this context, the right to happiness translates as an expression of the aspirations for the realization of the right to health. Thus, this chapter aims to understand, in the light of the Freudian perspective, the aspects of soul life that lead the individual to the exhausting task of seeking happiness and seeks to reflect the possible contributions that legal science can offer to the improvement of individual well-being as a right health in the context of global health. Freud's theories about the formation of the psychic apparatus, his conception of malaise caused by culture and legal interventions that can possibly contribute to the reduction of individual unhappiness are presented.


1997 ◽  
Vol 3 (1) ◽  
pp. 23-49 ◽  
Author(s):  
Alison Lakin

Instigated in response to the United Nation's ‘global change’ policy, the World Health Organisation is currently under-going major internal reform. There are indications that serious consideration is being given to the role that the rule of law should play within the international health field and how this should impact upon the WHO. Such developments are crucial if the WHO is to continue to playa leading role as advocate for health within the existing international framework. This article begins by examining the available legal powers as provided in its constitution and considers the limited impact that these powers have had to-date within the Organisation. The recent investigation of a framework treaty system based on the ‘convention-protocol’ approach is an exciting but problematic development, although a more systematic and comprehensive approach to normative issues would certainly be appropriate. This would be an ideal opportunity to initiate a comprehensive legal approach around normative issues using the WHO's constitutive legal powers based on the right to health and under the auspices of a ‘Health Academy’.


2015 ◽  
Vol 43 (S3) ◽  
pp. 17-21 ◽  
Author(s):  
Nils Daulaire ◽  
Abhay Bang ◽  
Göran Tomson ◽  
Joan N. Kalyango ◽  
Otto Cars

The right to health is enshrined in the constitution of the World Health Organization and numerous other international agreements. Yet today, an estimated 5.7 million people die each year (Table 1) from treatable infectious diseases, most of which are susceptible to existing antimicrobials if they were accessible. These deaths occur predominantly among populations living in poverty in low- and middle-income countries, and they greatly exceed the estimated 700,000 annual deaths worldwide currently attributed to antimicrobial resistance (AMR). Ensuring universal appropriate access to antimicrobials is not only a critical part of realizing the right to health, it is necessary for mobilizing effective collective action against the development and spread of AMR.


2012 ◽  
Vol 40 (2) ◽  
pp. 220-233 ◽  
Author(s):  
Joo-Young Lee ◽  
Paul Hunt

The Constitution of the World Health Organization (WHO) affirms that “the enjoyment of the highest attainable standard of health is one of the fundamental rights of every human being.” The Universal Declaration of Human Rights lays the foundations for the international framework for the right to health. This human right is now codified in numerous national constitutions, as well as legally binding international human rights treaties, such as the International Covenant on Economic, Social and Cultural Rights.Although medical care and access to medicines are vital features of the right to health, almost two billion people lack access to essential medicines, leading to immense avoidable suffering. Improving access to essential medicines could save 10 million lives each year, four million of them in Africa and South-East Asia alone. Gross inequity is a shocking feature of the world pharmaceutical situation.


1990 ◽  
Vol 64 (02) ◽  
pp. 267-269 ◽  
Author(s):  
A B Heath ◽  
P J Gaffney

SummaryAn International Standard for Streptokinase - Streptodomase (62/7) has been used to calibrate high purity clinical batches of SK since 1965. An international collaborative study, involving six laboratories, was undertaken to replace this standard with a high purity standard for SK. Two candidate preparations (88/826 and 88/824) were compared by a clot lysis assay with the current standard (62/7). Potencies of 671 i.u. and 461 i.u. were established for preparations A (88/826) and B (88/824), respectively.Either preparation appeared suitable to serve as a standard for SK. However, each ampoule of preparation A (88/826) contains a more appropriate amount of SK activity for potency testing, and is therefore preferred. Accelerated degradation tests indicate that preparation A (88/826) is very stable.The high purity streptokinase preparation, coded 88/826, has been established by the World Health Organisation as the 2nd International Standard for Streptokinase, with an assigned potency of 700 i.u. per ampoule.


2020 ◽  
Author(s):  
Micael Davi Lima de Oliveira ◽  
Kelson Mota Teixeira de Oliveira

According to the World Health Organisation, until 16 June, 2020, the number of confirmed and notified cases of COVID-19 has already exceeded 7.9 million with approximately 434 thousand deaths worldwide. This research aimed to find repurposing antagonists, that may inhibit the activity of the main protease (Mpro) of the SARS-CoV-2 virus, as well as partially modulate the ACE2 receptors largely found in lung cells, and reduce viral replication by inhibiting Nsp12 RNA polymerase. Docking molecular simulations were performed among a total of 60 structures, most of all, published in the literature against the novel coronavirus. The theoretical results indicated that, in comparative terms, paritaprevir, ivermectin, ledipasvir, and simeprevir, are among the most theoretical promising drugs in remission of symptoms from the disease. Furthermore, also corroborate indinavir to the high modulation in viral receptors. The second group of promising drugs includes remdesivir and azithromycin. The repurposing drugs HCQ and chloroquine were not effective in comparative terms to other drugs, as monotherapies, against SARS-CoV-2 infection.


2017 ◽  
Vol 68 (7) ◽  
pp. 1438-1441 ◽  
Author(s):  
Sorin Berbece ◽  
Dan Iliescu ◽  
Valeriu Ardeleanu ◽  
Alexandru Nicolau ◽  
Radu Cristian Jecan

Obesity represents a global health problem. According to the latest studies released by the World Health Organisation (WHO), 1.7 billion currently in excess of normal weight individuals, of which approx. 75% are overweight (body mass index - BMI 25 to 30). The common form of excess adipose tissue manifestation in overweight individuals is localized fat deposits with high (abdominal) or low (buttocks and thighs) disposition. Although the overweight can be corrected relatively easy by changing behavioral habits or food, a constant physical exercises program or following a diet food are not accessible to all through the efforts of will, financial and time involved. Several methods have been studied and tested over time to eliminate more or less invasive fat deposits with varying efficacy and adverse effects. Chemical lipolysis using phosphatidylcholine as the basic substance was initially used in hypercholesterolemia and its complications and was rapidly adopted in mesotherapy techniques for the treatment of fat deposits. This study reveals the results obtained using Dermastabilon on a sample of 16 patients, the time allocated to treatment and discomfort being minimal, and rapid and notable results. There were no side effects.


Sign in / Sign up

Export Citation Format

Share Document